Financial summary
Consolidated three-year summary
Year ended 30 June 2009
| Year ended 30 June 2009 £'000 |
Year ended 30 June 2008 £'000 |
Year ended 30 June 2007 £'000 |
|
|---|---|---|---|
| Results | |||
| Operating loss | (7,635) | (5,880) | (3,536) |
| Loss before tax | (6,500) | (4,945) | (3,236) |
| Loss attributable to equity holders of Neuropharm Group plc | (5,884) | (4,191) | (3,236) |
| Assets employed | |||
| Non-current assets | 16 | 223 | 59 |
| Current assets | 7,795 | 13,864 | 18,109 |
| Current liabilities | (554) | (1,332) | (1,365) |
| Non-current liabilities | - | (97) | (101) |
| Net assets | 7,257 | 12,658 | 16,702 |
| Financed by | |||
| Equity | 7,257 | 12,658 | 16,702 |
| Key statistics | |||
| Basic and diluted loss per share | (18.7)p | (13.3)p | (16.6)p |